Bilimetrix is an R&D biomed company that develops an in vitro Point of Care (POC) system for early diagnosis of hyperbilirubinemia. Its Bilistick System is used to estimate the plasma total bilirubin concentration, triage newborns, and evaluate the risk of hyperbilirubinemia during discharge from birthing centers, as well as to assess the severity of jaundice in newborns during follow up visits.